文献速递瓣膜外科

机器人二尖瓣修复术学习曲线的消除:1400例患者结果

Eliminating the learning curve in robotic mitral valve repair: Results from 1400 patients.
PubMed 文献 · J Thorac Cardiovasc Surg · 2025-01-01

该研究基于2005至2023年单中心1410例机器人二尖瓣手术患者,采用累积和(CUSUM)分析评估4位外科医生的学习曲线。项目整体学习曲线在94例后趋于稳定,此后风险调整并发症与死亡率持续优于预测值;后续外科医生自始即无学习曲线,退行性二尖瓣修复率达99.5%,5年免于中度及以上二尖瓣反流为95%。

要点

  • 经验丰富项目中的外科医生学习机器人二尖瓣手术时未出现劣于预测的学习曲线。
  • 项目学习曲线在94例后趋于稳定,此后风险调整结局持续优于预测。
  • 退行性二尖瓣修复率99.5%,5年免于中度及以上二尖瓣反流为95%。

核心结论

  • 在经验丰富的项目中,外科医生可在不出现以劣于预测临床结局定义的学习曲线的情况下学习机器人二尖瓣手术,退行性二尖瓣修复率超过99%且耐久性良好。

研究设计与样本

  • 单中心回顾性研究,纳入2005至2023年由4位处于职业生涯不同阶段的外科医生实施的1410例机器人二尖瓣手术患者,数据来自机构注册数据库。
  • 使用累积和(CUSUM)分析构建以STS风险调整并发症(卒中、肾衰竭、心脏再手术、再插管或延长通气)与死亡率为主要结局的学习曲线。

主要发现

  • 患者中位年龄63岁(IQR 54-70岁),男性占65.3%,STS预测并发症与死亡风险中位数5.9%(IQR 4.3%-8.5%)。
  • 病因以退行性为主(1237例,88%),其中869例(70%)为孤立P2脱垂。
  • 总体手术死亡率为0.3%(n=4),其中3例死亡发生在前1000例;复合并发症与死亡率为4.4%(n=62)。
  • 退行性病变修复率为99.5%(n=1234/1237),5年免于中度及以上二尖瓣反流为95%。
  • 项目学习曲线在94例后趋于稳定,此后风险调整并发症与死亡率持续优于预测;后续外科医生自始结局即优于预测,无学习曲线,风险调整并发症与体外循环时间逐步改善。

关键数值与推荐

  • 退行性二尖瓣修复率99.5%(1234/1237),5年免于中度及以上二尖瓣反流95%。
  • 项目学习曲线在94例后趋于稳定,此后风险调整并发症与死亡率持续优于预测。

临床怎么用

  • 在经验丰富的高流量机器人二尖瓣项目中,后续外科医生可在不牺牲风险调整结局的前提下开展机器人二尖瓣手术。
  • 项目层面应关注早期病例积累与团队经验,以度过约94例的项目学习曲线阶段。

局限性

  • 单中心机构注册数据,结果来自经验丰富项目,外推至低流量或新建项目需谨慎;为回顾性设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate learning curves of surgeons performing robotic mitral surgery at an experienced program. METHODS: A total of 1410 patients undergoing robotic mitral surgery between 2005 and 2023 performed by 4 surgeons (from early to late in their careers) were identified from an institutional registry. Learning curves for the primary outcome of Society of Thoracic Surgeons (STS) risk-adjusted morbidity (stroke, renal failure, cardiac reoperation, reintubation, or prolonged ventilation) and mortality were constructed using cumulative sum analysis. RESULTS: The median patient age was 63 years (interquartile range [IQR], 54-70 years), 65.3% of the patients were male, and the patients' median STS predicted risk of morbidity and mortality was 5.9% (IQR, 4.3%-8.5%). Etiology was degenerative in 1237 patients (88%), of whom 869 (70%) had isolated P2 prolapse. Overall operative mortality was 0.3% (n = 4), with 3 deaths occurring in the first 1000 cases. Composite morbidity and mortality was 4.4% (n = 62). The degenerative repair rate was 99.5% (n = 1234/1237), with a 95% freedom from moderate or worse mitral regurgitation at 5 years. The program learning curve peaked at case 94, after which risk-adjusted morbidity and mortality was consistently better than predicted. Subsequent surgeons learned robotic mitral surgery with better-than-predicted outcomes from the outset-that is, no learning curve, with progressive improvement in risk-adjusted complications and cardiopulmonary bypass times. CONCLUSIONS: Surgeons in an experienced program can learn robotic mitral surgery without a learning curve defined by worse-than-predicted clinical outcomes, achieving degenerative mitral repair rates >99% and good durability.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Chikwe J, Tam D, Hasan I, et al. Eliminating the learning curve in robotic mitral valve repair: Results from 1400 patients. J Thorac Cardiovasc Surg. 2025. PMID: 41177574. doi:10.1016/j.jtcvs.2025.01.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。